1. Home
  2. MRUS vs KAI Comparison

MRUS vs KAI Comparison

Compare MRUS & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • KAI
  • Stock Information
  • Founded
  • MRUS 2003
  • KAI 1991
  • Country
  • MRUS Netherlands
  • KAI United States
  • Employees
  • MRUS N/A
  • KAI N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • KAI Industrial Machinery/Components
  • Sector
  • MRUS Health Care
  • KAI Industrials
  • Exchange
  • MRUS Nasdaq
  • KAI Nasdaq
  • Market Cap
  • MRUS 4.1B
  • KAI 4.0B
  • IPO Year
  • MRUS 2016
  • KAI N/A
  • Fundamental
  • Price
  • MRUS $67.47
  • KAI $326.95
  • Analyst Decision
  • MRUS Strong Buy
  • KAI Buy
  • Analyst Count
  • MRUS 13
  • KAI 2
  • Target Price
  • MRUS $90.92
  • KAI $340.00
  • AVG Volume (30 Days)
  • MRUS 550.9K
  • KAI 100.7K
  • Earning Date
  • MRUS 10-30-2025
  • KAI 10-28-2025
  • Dividend Yield
  • MRUS N/A
  • KAI 0.41%
  • EPS Growth
  • MRUS N/A
  • KAI N/A
  • EPS
  • MRUS N/A
  • KAI 8.98
  • Revenue
  • MRUS $56,228,000.00
  • KAI $1,024,121,000.00
  • Revenue This Year
  • MRUS $57.42
  • KAI N/A
  • Revenue Next Year
  • MRUS $0.23
  • KAI $5.17
  • P/E Ratio
  • MRUS N/A
  • KAI $36.55
  • Revenue Growth
  • MRUS 59.77
  • KAI 1.74
  • 52 Week Low
  • MRUS $33.19
  • KAI $281.30
  • 52 Week High
  • MRUS $69.20
  • KAI $429.95
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 58.81
  • KAI 47.04
  • Support Level
  • MRUS $62.80
  • KAI $314.64
  • Resistance Level
  • MRUS $67.84
  • KAI $342.15
  • Average True Range (ATR)
  • MRUS 2.39
  • KAI 9.87
  • MACD
  • MRUS -0.22
  • KAI -1.63
  • Stochastic Oscillator
  • MRUS 73.67
  • KAI 32.52

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

Share on Social Networks: